Moderna's COVID-19 vaccine safe for older adults, extended trials reveal

New trials conducted by Moderna Inc. revealed that its COVID-19 vaccine appeared safe and worked well with older ults. findings of trials were published in New England Journal of Medicine and revealed that vaccine produced virus neutralizing antibodies at levels similar to those seen in ults. Moderna is alrey testing 100 microgram dose of it’s vaccine in Phase 3, and positive results would make it US’ first vaccine.

Conducted on older ults

latest research was conducted as an extension of company’s Phase I safety trials which were first conducted in individuals d 18-55. For purpose, researchers tested two doses of Moderna’s vaccine - 25 micrograms and 100 micrograms - in 40 ults d 56 to 70 and 71 and older.

In aftermath, y found that in ults who received two injections  of 100 microgram dose 28 days apart,  vaccine produced immune responses roughly in line with those produced in young ults. Although older ults showed some side effects like heaches , fatigue, body aches, chills, injections site, y were generally mild to mediate on intensity scale. Elaborating about side effects in study, which offered a complete picture of vaccine safety, researchers said that side effects were roughly on par with high-dose flu shots.

Re: COVID-19 Vaccine Trial Blueprints Revealed By Moderna, Pfizer Amid Calls For Transparency

Re: Moderna's COVID-19 Vaccine: 13,194 People Enroll For Phase 3 Trials

Recently, Moderna became first firm to publish complete blueprints of its clinical trials amid growing calls for transparency followed by Pfizer. Moderna is one of nine companies with ir COVID-19 vaccine candidate in late sts of clinical trials while vel coronavirus outbreak has continued to tighten its grip across globe. Ar US-based pharmaceutical firm, Pfizer which is also carrying out Phase 3 trials in America reportedly conformed to similar move shortly after, leing to mounting pressure on remaining companies to do same. 

Re: Trump ministration Signs $1.5 Billion Deal With Moderna For COVID-19 Vaccine Doses

Re: COVID-19: Moderna, Pfizer To Include HIV+ Volunteers In Final St Of Vaccine Trials